MLH1 and colorectal carcinoma: For instance, the data for MLH1 loss shows an association with more lymph node positivity, which suggests that perhaps we should specifically consider that protein is missing when using the presence or absence of dMMR to predict the efficacy of immunotherapy in CRC patients.